Post-authorization Safety Study of Iptacopan in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Using Data From the IPIG PNH Registry
Clinical trial NCT06903234 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06903234
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-03-31
- Primary completion
- 2029-10-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.